v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net increase (decrease) in net assets resulting from operations $ 121,815 $ 92,714
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net realized (gain) loss on investments (4,500) (764)
Net realized (gain) loss on foreign currency forward contracts 7 (36)
Net change in unrealized (appreciation) depreciation on investments (1,422) (2,741)
Net change in unrealized (appreciation) depreciation on interest rate swaps and options, inclusive of hedging effects (956) (1,298)
Net accretion on debt instruments (9,943) (8,641)
Net paydown gain on debt instruments (3,844) (2,649)
Interest received in-kind (3,030) (2,244)
Purchases and drawdowns of investments (991,249) (690,798)
Proceeds from sales and paydowns of investments 470,365 264,656
Net settlements on derivative contracts 0 36
Amortization of deferred financing costs 3,635 3,570
Amortization of deferred offering costs 873 1,098
Change in operating assets and liabilities:    
(Increase) decrease in interest receivable (154) (2,500)
(Increase) decrease in other assets (1,281) (81)
(Increase) decrease in prepaid expenses 278 553
Increase (decrease) in interest payable (1,584) (5,161)
Increase (decrease) in accrued expenses and other liabilities payable to affiliate (763) (90)
Increase (decrease) in income incentive fees payable 830 1,253
Increase (decrease) in management fees payable 1,159 1,002
Increase (decrease) in deferred tax liability (294) 999
Increase (decrease) in deferred income 221 (287)
Increase (decrease) in capital gains incentive fees payable 469 277
Net cash used in operating activities (419,377) (351,080)
Cash flows from financing activities    
Dividends paid (83,877) (66,747)
Payments for repurchase of common shares (51,916) (38,095)
Proceeds from issuance of common shares 350,703 387,499
Borrowings on debt 842,000 807,700
Payments on debt (582,500) (761,500)
Payments for deferred financing costs (3,948) (1,763)
Payments for deferred offering costs (1,205) (880)
Net cash provided by financing activities 469,257 326,214
Net change in cash 49,880 (24,866)
Cash, cash equivalents and restricted cash, beginning of period 184,802 161,064
Cash, cash equivalents and restricted cash, end of period 234,682 136,198
Supplemental and non-cash information    
Distributions reinvested 35,043 23,130
Cash paid during the period for interest 66,916 67,121
Dividends payable 21,529 16,550
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated statements of assets and liabilities:    
Cash and cash equivalents 168,944 73,634
Restricted cash 65,738 62,564
Total cash, cash equivalents and restricted cash 234,682 136,198
Foreign currency forward contracts    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts $ (9) $ 52